关于药品在欧盟上市的相关问题?欧盟的上市授权持有者和药品生产者,可以不是同一家企业,那么,比如原研生产厂家可以把自己生产的产品在其它欧盟国家上市的所有权转卖给其它企业,其它企业可否使用不同的商标(包装及说明书))进行销售,但是生产厂家还是原研厂家?此时该制剂是否可以作为原研品来使用? 例如下面这段药品英文说明书所描述的: Boehringer Ingelheim Limited, Consumer Healthcare, Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS, United Kingdom. Manufacturer Beaufour Ipsen Industrie, Rue Ethe Virton, 28100 Dreux, France. This medicinal product is authorised in the Member States of the EEA under the following names: Forlax 10g in Austria, Belgium, Czech Republic, Estonia, France, Latvia, Lithuania, Luxemburg, Poland, Portugal, Slovakia, and The Netherlands; Dulcolax M Balance in Germany, Tanilas 10g in Greece, Idrolax in Ireland, Paxabel 10g in Italy, and Dulcobalance in the United Kingdom查看更多2个回答 . 18人已关注